The synthesis of hepatocyte-targeted prodrugs was carried out by using a β-elemene derivative W-105 served as the anti-tumor pharmacophore drug payload, Gal as the hepatocyte-targeting ligand, and the disulfide responsive to the tumor cells (high concentration of glutathione) served as the linking group. This evidence concerns the gene GAL and neoplasm.